Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Riethdorf

Showing results (71-80 of 172) with videos related to

Pageof 18
Sort By:
Plos One|June 10, 2021
Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancerThaer S A Abdalla, Jan Meiners, Sabine Riethdorf, et al.
Archives of Gynecology and Obstetrics|July 22, 2023
Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collectionThomas M Deutsch, Chiara Fischer, Fabian Riedel, et al.
Frontiers in Oncology|November 28, 2022
Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinomaThorben Fründt, Johann von Felden, Jenny Krause, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavityAlexander Gröbe, Marco Blessmann, Henning Hanken, et al.
Cancer Research|November 18, 2015
Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein ResponseKai Bartkowiak, Marcel Kwiatkowski, Friedrich Buck, et al.
Oncoimmunology|May 12, 2020
Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)Sonja Bergmann, Anja Coym, Leonie Ott, et al.
The American Journal of Pathology|May 14, 2013
Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastasesIna Hohensee, Katrin Lamszus, Sabine Riethdorf, et al.
Plos One|December 6, 2011
Quantitative high-resolution genomic analysis of single cancer cellsJuliane Hannemann, Sönke Meyer-Staeckling, Dirk Kemming, et al.
Cells|October 27, 2020
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA AssayYassine Belloum, Melanie Janning, Malte Mohme, et al.
Breast Cancer Research and Treatment|May 22, 2020
HER2-targeted therapy influences CTC status in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Carlo Fremd, et al.
Pageof 18

Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
Plos One|June 10, 2021
Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancerThaer S A Abdalla, Jan Meiners, Sabine Riethdorf, et al.
Archives of Gynecology and Obstetrics|July 22, 2023
Relationship of Ki-67 index in biopsies of metastatic breast cancer tissue and circulating tumor cells (CTCs) at the time of biopsy collectionThomas M Deutsch, Chiara Fischer, Fabian Riedel, et al.
Frontiers in Oncology|November 28, 2022
Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinomaThorben Fründt, Johann von Felden, Jenny Krause, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavityAlexander Gröbe, Marco Blessmann, Henning Hanken, et al.
Cancer Research|November 18, 2015
Disseminated Tumor Cells Persist in the Bone Marrow of Breast Cancer Patients through Sustained Activation of the Unfolded Protein ResponseKai Bartkowiak, Marcel Kwiatkowski, Friedrich Buck, et al.
Oncoimmunology|May 12, 2020
Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)Sonja Bergmann, Anja Coym, Leonie Ott, et al.
The American Journal of Pathology|May 14, 2013
Frequent genetic alterations in EGFR- and HER2-driven pathways in breast cancer brain metastasesIna Hohensee, Katrin Lamszus, Sabine Riethdorf, et al.
Plos One|December 6, 2011
Quantitative high-resolution genomic analysis of single cancer cellsJuliane Hannemann, Sönke Meyer-Staeckling, Dirk Kemming, et al.
Cells|October 27, 2020
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA AssayYassine Belloum, Melanie Janning, Malte Mohme, et al.
Breast Cancer Research and Treatment|May 22, 2020
HER2-targeted therapy influences CTC status in metastatic breast cancerThomas M Deutsch, Sabine Riethdorf, Carlo Fremd, et al.
Pageof 18